Your shopping cart is empty

Subscriber login

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

Check out our free and informative ezines and sign up now

Home > Newsletters > Drug Industry Daily > Process Control Deficiencies Land Exemplar Pharmaceuticals a Form 483

Drug Industry Daily

July 12, 2012 | Vol. 11 No. 136

Process Control Deficiencies Land Exemplar Pharmaceuticals a Form 483

Exemplar Pharmaceuticals, a contract manufacturer of nasal sprays and other aerosol-based drugs, was handed a Form 483 for process control deficiencies tied to filling foul ups.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
Email This Article
RSS
Free Trial
Archives
Sample PDF

Gilead Form 483 Provides Insight into FDA’s Rejection of HIV Drugs Novartis 483 Highlights Rocky Remediation at Nebraska Plant Concerns with Contract Manufacturer Draw Complete Response for Allergan’s Levadex FOIA Log

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.